NICE(NICE)
NICE
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $3.18B | $3.49B | $3.92B | $4.55B | $5.16B |
| Low | $3.17B | $3.38B | $3.85B | $4.47B | $5.07B |
| High | $3.21B | $3.56B | $3.97B | $4.60B | $5.22B |
| EBITDA Avg | $1.24B | $1.36B | $1.53B | $1.78B | $2.01B |
| Low | $1.24B | $1.32B | $1.50B | $1.75B | $1.98B |
| High | $1.26B | $1.39B | $1.55B | $1.80B | $2.04B |
| EBIT Avg | $1.11B | $1.21B | $1.37B | $1.58B | $1.80B |
| Low | $1.10B | $1.18B | $1.34B | $1.56B | $1.76B |
| High | $1.12B | $1.24B | $1.38B | $1.60B | $1.82B |
| Net Income Avg | $701M | $798M | $975M | $1.27B | $1.59B |
| Low | $696M | $765M | $952M | $1.24B | $1.55B |
| High | $706M | $832M | $989M | $1.29B | $1.61B |
| EPS Avg | $11.09 | $12.66 | $15.39 | $20.07 | $25.08 |
| Low | $10.99 | $12.07 | $15.04 | $19.61 | $24.50 |
| High | $11.15 | $13.15 | $15.61 | $20.36 | $25.44 |
| Analysts (Rev / EPS) | 11 / 13 | 8 / 13 | 6 / 9 | 7 / 11 | 7 / 5 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $796M | $848M | $840M | $841M | $872M | $933M | $928M | $937M |
| Low | $790M | $841M | $833M | $834M | $865M | $926M | $920M | $929M |
| High | $802M | $856M | $847M | $849M | $880M | $942M | $936M | $946M |
| EBITDA Avg | $311M | $331M | $328M | $329M | $341M | $365M | $362M | $366M |
| Low | $309M | $329M | $325M | $326M | $338M | $362M | $359M | $363M |
| High | $313M | $334M | $331M | $332M | $344M | $368M | $366M | $369M |
| EBIT Avg | $277M | $295M | $292M | $293M | $303M | $325M | $323M | $326M |
| Low | $275M | $293M | $290M | $290M | $301M | $322M | $320M | $324M |
| High | $279M | $298M | $295M | $296M | $306M | $328M | $326M | $329M |
| Net Income Avg | $169M | $184M | $181M | $182M | $194M | $213M | $212M | $217M |
| Low | $167M | $182M | $179M | $180M | $192M | $211M | $210M | $215M |
| High | $173M | $186M | $183M | $184M | $196M | $216M | $215M | $220M |
| EPS Avg | $2.79 | $3.04 | $2.98 | $3.00 | $3.20 | $3.52 | $3.50 | $3.59 |
| Low | $2.76 | $3.01 | $2.95 | $2.97 | $3.16 | $3.48 | $3.46 | $3.55 |
| High | $2.86 | $3.08 | $3.02 | $3.04 | $3.24 | $3.56 | $3.54 | $3.63 |
| Analysts (Rev / EPS) | 10 / 10 | 5 / 4 | 5 / 4 | 5 / 4 | 5 / 4 | 5 / 4 | 4 / 5 | 4 / 5 |